Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection and genetic characterisation of ESBL, carbapenemase, and mcr-1 genes in Gram-negative bacterial isolates from companion animals in Batna, Algeria.

Antonie van Leeuwenhoek·2025
Same author

Case Report: Giant lung hamartoma : An usual cause of lobectomy in a five-year child.

F1000Research·2025
Same author

Synthesis of a new potassium-substituted lead fluorapatite and its structural characterization.

RSC advances·2024
Same author

Removal of airway foreign body using flexible bronchoscopy in children.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2024
Same author

COPD after "Tabouna" Exposure: A Distinct Phenotype in Tunisian Women?

Journal of clinical medicine·2023
Same author

Prevalence of AmpC, ESBL, and colistin resistance genes in Enterobacterales isolated from ready-to-eat food in Algeria.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2023

Related Experiment Video

Updated: Jun 5, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

N-(Hydroxymethyl)ibogaine.

Raoudha Mezghani Jarraya, Amira Bouaziz, Besma Hamdi

    Acta Crystallographica. Section E, Structure Reports Online
    |January 5, 2011
    PubMed
    Summary

    Researchers synthesized a new ibogaine derivative, 16-hydroxy-methyl-12-methoxy-ibogamine, using formaldehyde. Its crystal structure reveals stabilization via a hydrogen bond, confirmed by NMR spectroscopy.

    Area of Science:

    • Organic Chemistry
    • Crystallography
    • Spectroscopy

    Background:

    • Ibogaine is a naturally occurring psychoactive indole alkaloid.
    • Derivatives of ibogaine are explored for potential therapeutic applications.
    • Understanding the structural properties of ibogaine derivatives is crucial for drug development.

    Purpose of the Study:

    • To synthesize a novel ibogaine derivative, 16-hydroxy-methyl-12-methoxy-ibogamine.
    • To elucidate the crystal structure of the newly synthesized compound.
    • To confirm the identity and structural features using spectroscopic methods.

    Main Methods:

    • Chemical synthesis involving the reaction of ibogaine with a formaldehyde-acetic acid solution.
    • X-ray crystallography for determining the three-dimensional crystal structure.

    More Related Videos

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
    08:56

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

    Published on: November 30, 2022

    Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
    08:49

    Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

    Published on: October 16, 2013

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
    06:06

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

    Published on: February 5, 2018

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
    08:56

    Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

    Published on: November 30, 2022

    Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
    08:49

    Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

    Published on: October 16, 2013

  • One- and two-dimensional Nuclear Magnetic Resonance (NMR) spectroscopy for structural confirmation.
  • Main Results:

    • Successful synthesis of 16-hydroxy-methyl-12-methoxy-ibogamine (C(21)H(28)N(2)O(2)).
    • The crystal structure is stabilized by a significant inter-molecular O-H⋯N hydrogen bond.
    • NMR data confirmed the chemical structure and identity of the synthesized compound.

    Conclusions:

    • A new ibogaine derivative has been synthesized and characterized.
    • The crystal structure provides insights into the intermolecular interactions of ibogaine derivatives.
    • This work contributes to the understanding of the iboga indole family and may inform future research in medicinal chemistry.